Open Access · CC BY 4.0
Could metacognitive therapy be a contender for first-line treatment for functional neurological disorder? The case for clinical trials
Frontiers in Psychiatry · 10.11.2026 · 17
DOI: 10.3389/fpsyt.2026.1978587 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Psychiatry, online erschienen am 10.11.2026. Verfasst von Nikki S. Scheiner. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Scheiner, N. S. (2026). Could metacognitive therapy be a contender for first-line treatment for functional neurological disorder? The case for clinical trials. Frontiers in Psychiatry, 17. https://doi.org/10.3389/fpsyt.2026.1978587
Vancouver
Scheiner NS. Could metacognitive therapy be a contender for first-line treatment for functional neurological disorder? The case for clinical trials. Frontiers in Psychiatry. 2026;17. doi:10.3389/fpsyt.2026.1978587
BibTeX
@article{Scheiner2026,
author = {Scheiner, Nikki S.},
title = {Could metacognitive therapy be a contender for first-line treatment for functional neurological disorder? The case for clinical trials},
journal = {Frontiers in Psychiatry},
year = {2026},
volume = {17},
doi = {10.3389/fpsyt.2026.1978587}
}
EUVIMED